XPERYS
DEAD

Serial Number

97146276

Owner

VCL Bidco B.V.

Attorney

James C. Watson

Filing Date

Nov 29, 2021

Add to watchlist:

No watchlists yet
View on USPTO

XPERYS Trademark

Serial Number: 97146276

XPERYS is a trademark filed by VCL Bidco B.V. on November 29, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 39 (Transportation & Storage), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

VCL Bidco B.V.

Marconistraat 16
Rotterdam 3029AK , NL

Entity Type: 99

Trademark Details

Filing Date

November 29, 2021

Registration Date

Not Registered

Goods & Services

Transport; Packaging and storage of goods; courier services with regard to the storage, transport and delivery of products, including of pharmaceutical and diagnostic products and material; tracking and tracing of shipments; providing information and advice in relation to the aforementioned services

Pharmaceuticals and medical preparations and products

Business management, organization and administration; Office functions; Services comprising the collection and recording of data; setting up data in computer databases and management of data in computer databases; Compilation of information into computer databases; Business management and organization consultancy; Business management consultancy; Commercial intermediation services; Customer loyalty services for commercial, promotional and/or advertising purposes; Business management for a trade company and for a service company; providing commercial information services relating to the pharmaceutical industry; Market research; Business consultancy services in the pharmaceutical field; maintenance and updating data in medical databases

Human healthcare services; Medical services; providing information relating to health care and medical information; Medical diagnostic services; Medical laboratory services for the analysis of samples taken from patients; conducting medical screenings, namely, preclinical screenings; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical testing for diagnostic or treatment purposes; Medical analysis services for the diagnosis of cancer; medical information services provided by means of interactive medical databases; analysis and evaluation services about the results and data obtained through conducting medical examinations; consultancy and information services relating to all aforementioned services; all the aforementioned services also provided online, via computer networks and the internet

Surgical, medical, dental and veterinary apparatus and instruments

Scientific and technological services and research and design relating thereto; Industrial analysis and industrial research; medical and pharmacological research services; preclinical research; providing medical and scientific research information in the field of epidemiology, pharmaceuticals, preclinical and clinical trials; Bacteriological research and testing; Research and development of vaccines, pharmaceutical preparations and medicines; conducting scientific preclinical and clinical trials; assay development; scientific research for medical purposes, namely, diagnostic, preclinical and clinical research and conducting diagnostic, preclinical and clinical trials; testing services, authentication services and quality control; Laboratory services, including laboratory research services and testing; Blood analysis services; testing and research on the subject of pharmaceuticals; Natural science services; Research relating to biotechnology; Research in the field of gene therapy; epidemiological research; providing information, analysis and evaluation about the results and data obtained through scientific, technological and pharmaceutical research to and trials for pharmaceutical products; Development of testing methods; research and testing services in the fields of serology, bacteriology, virology, as well as providing scientific evaluation and analysis of the results of this research and testing; research relating to molecular sciences; consultancy and information services relating to all aforementioned services

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 19, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 19, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 19, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 14, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 14, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 14, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2022 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Feb 17, 2022 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 16, 2022 PARI
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Dec 20, 2021 AMPX
ASSIGNED TO LIE
Dec 18, 2021 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 15, 2021 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 2, 2021 NWOS
NEW APPLICATION ENTERED
Dec 2, 2021 NWAP